Drugs / rHIgM12B7
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00658892 | Apr 2008 → Feb 2010 | cutaneous melanoma | Mayo Clinic | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rHIgM12B7 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00658892 ↗ |
| Target | PDCD1LG2 | “Programmed cell death 1 ligand 2 cross-linking agent” CHEMBL2109309 ↗ |